Table 3.
Characteristics | Total |
Involved vessels |
P value | |
Single vessel | Multivessel | |||
Total | 571 | 342 (59.9) | 229 (40.1) | - |
Contrast volume (mL) | 135.65 ± 44.28 | 134.3 ± 42.97 | 137.66 ± 46.18 | 0.375 |
Fluro time (min) | 13.2 ± 6.69 | 12.83 ± 6.53 | 13.75 ± 6.91 | 0.107 |
Number of stents deployed | 1.09 ± 0.66 | 1.01 ± 0.44 | 1.21 ± 0.87 | < 0.001 |
Post-procedure TIMI flow grade | ||||
TIMI - 0 | 3 (0.5) | 2 (0.6) | 1 (0.4) | 0.426 |
TIMI - 1 | 3 (0.5) | 2 (0.6) | 1 (0.4) | |
TIMI - 2 | 9 (1.6) | 3 (0.9) | 6 (2.6) | |
TIMI - 3 | 556 (97.4) | 335 (98) | 221 (96.5) | |
Post-procedure in-hospital outcomes | ||||
Composite adverse events | 11 (1.9) | 6 (1.8) | 5 (2.2) | 0.715 |
Re-infarction | 3 (0.5) | 3 (0.9) | 0 (0) | 0.155 |
Cardiogenic shock | 2 (0.4) | 0 (0) | 2 (0.9) | 0.083 |
Heart failure | 2 (0.4) | 0 (0) | 2 (0.9) | 0.083 |
Dialysis | 1 (0.2) | 0 (0) | 1 (0.4) | 0.221 |
Mortality | 7 (1.2) | 3 (0.9) | 4 (1.7) | 0.355 |
TIMI: Thrombolysis in myocardial infarction.